BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 31484505)

  • 1. A phase III randomized-controlled, single-blind trial to improve quality of life with stereotactic body radiotherapy for patients with painful bone metastases (ROBOMET).
    Mercier C; Dirix P; Ost P; Billiet C; Joye I; Vermeulen P; Lievens Y; Verellen D
    BMC Cancer; 2019 Sep; 19(1):876. PubMed ID: 31484505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pain Response After Stereotactic Body Radiation Therapy Versus Conventional Radiation Therapy in Patients With Bone Metastases-A Phase 2 Randomized Controlled Trial Within a Prospective Cohort.
    Pielkenrood BJ; van der Velden JM; van der Linden YM; Bartels MMT; Kasperts N; Verhoeff JJC; Eppinga WSC; Gal R; Verlaan JJ; Verkooijen HML
    Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):358-367. PubMed ID: 33333200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic body radiotherapy for osseous low alpha-beta resistant metastases for pain relief-SOLAR-P.
    Nguyen EK; Quan K; Parpia S; Tran S; Swaminath A
    Radiat Oncol; 2021 Sep; 16(1):170. PubMed ID: 34479581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-Fraction Stereotactic vs Conventional Multifraction Radiotherapy for Pain Relief in Patients With Predominantly Nonspine Bone Metastases: A Randomized Phase 2 Trial.
    Nguyen QN; Chun SG; Chow E; Komaki R; Liao Z; Zacharia R; Szeto BK; Welsh JW; Hahn SM; Fuller CD; Moon BS; Bird JE; Satcher R; Lin PP; Jeter M; O'Reilly MS; Lewis VO
    JAMA Oncol; 2019 Jun; 5(6):872-878. PubMed ID: 31021390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re-irradiation for painful bone metastases using stereotactic body radiotherapy.
    Ogawa H; Ito K; Shimizuguchi T; Furuya T; Nihei K; Karasawa K
    Acta Oncol; 2018 Dec; 57(12):1700-1704. PubMed ID: 30280622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized phase II trial evaluating pain response in patients with spinal metastases following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy.
    Sprave T; Verma V; Förster R; Schlampp I; Bruckner T; Bostel T; Welte SE; Tonndorf-Martini E; Nicolay NH; Debus J; Rief H
    Radiother Oncol; 2018 Aug; 128(2):274-282. PubMed ID: 29843899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2/3 trial.
    Sahgal A; Myrehaug SD; Siva S; Masucci GL; Maralani PJ; Brundage M; Butler J; Chow E; Fehlings MG; Foote M; Gabos Z; Greenspoon J; Kerba M; Lee Y; Liu M; Liu SK; Thibault I; Wong RK; Hum M; Ding K; Parulekar WR;
    Lancet Oncol; 2021 Jul; 22(7):1023-1033. PubMed ID: 34126044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAT RT: a prospective pilot clinical trial of Scan-Plan-QA-Treat stereotactic body radiation therapy for painful osseous metastases.
    Wilson DD; Alonso CE; Sim AJ; Peck T; Handsfield LL; Chen Q; Blackhall L; Showalter TN; Reardon KA; Read PW
    Ann Palliat Med; 2019 Jul; 8(3):221-230. PubMed ID: 30691281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase I dose-escalation trial of stereotactic ablative body radiotherapy for non-spine bone and lymph node metastases (DESTROY-trial).
    Mercier C; Dirix P; Meijnders P; Vermeulen P; Van Laere S; Debois H; Huget P; Verellen D
    Radiat Oncol; 2018 Aug; 13(1):152. PubMed ID: 30126440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexamethasone for the prevention of a pain flare after palliative radiotherapy for painful bone metastases: a multicenter double-blind placebo-controlled randomized trial.
    Westhoff PG; de Graeff A; Geerling JI; Reyners AK; van der Linden YM
    BMC Cancer; 2014 May; 14():347. PubMed ID: 24885354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pain REduction with bone metastases STereotactic radiotherapy (PREST): A phase III randomized multicentric trial.
    Cellini F; Manfrida S; Deodato F; Cilla S; Maranzano E; Pergolizzi S; Arcidiacono F; Di Franco R; Pastore F; Muto M; Borzillo V; Donati CM; Siepe G; Parisi S; Salatino A; D'Agostino A; Montesi G; Santacaterina A; Fusco V; Santarelli M; Gambacorta MA; Corvò R; Morganti AG; Masiello V; Muto P; Valentini V
    Trials; 2019 Oct; 20(1):609. PubMed ID: 31661034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local response and pathologic fractures following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy for spinal metastases - a randomized controlled trial.
    Sprave T; Verma V; Förster R; Schlampp I; Hees K; Bruckner T; Bostel T; El Shafie RA; Welzel T; Nicolay NH; Debus J; Rief H
    BMC Cancer; 2018 Aug; 18(1):859. PubMed ID: 30170568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of extracranial stereotactic body radiation therapy (SBRT) added to standard treatment in patients with solid tumors (breast, prostate and non-small cell lung cancer) with up to 3 bone-only metastases: study protocol for a randomised phase III trial (STEREO-OS).
    Thureau S; Marchesi V; Vieillard MH; Perrier L; Lisbona A; Leheurteur M; Tredaniel J; Culine S; Dubray B; Bonnet N; Asselain B; Salleron J; Faivre JC
    BMC Cancer; 2021 Feb; 21(1):117. PubMed ID: 33541288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Radiotherapy on Painful Bone Metastases: A Secondary Analysis of the NCIC Clinical Trials Group Symptom Control Trial SC.23.
    McDonald R; Ding K; Brundage M; Meyer RM; Nabid A; Chabot P; Coulombe G; Ahmed S; Kuk J; Dar AR; Mahmud A; Fairchild A; Wilson CF; Wu JSY; Dennis K; DeAngelis C; Wong RKS; Zhu L; Chan S; Chow E
    JAMA Oncol; 2017 Jul; 3(7):953-959. PubMed ID: 28196208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of Life Following Stereotactic Body Radiotherapy
    Sprave T; Verma V; Förster R; Schlampp I; Bruckner T; Bostel T; El Shafie RA; Nicolay NH; Debus J; Rief H
    Anticancer Res; 2018 Aug; 38(8):4961-4968. PubMed ID: 30061276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-intensified hypofractionated stereotactic body radiation therapy for painful spinal metastases: Results of a phase 2 study.
    Guckenberger M; Sweeney RA; Hawkins M; Belderbos J; Andratschke N; Ahmed M; Madani I; Mantel F; Steigerwald S; Flentje M
    Cancer; 2018 May; 124(9):2001-2009. PubMed ID: 29499073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fractionated radiosurgery for painful spinal metastases: DOSIS - a phase II trial.
    Guckenberger M; Hawkins M; Flentje M; Sweeney RA
    BMC Cancer; 2012 Nov; 12():530. PubMed ID: 23164174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized Pilot Study of 20 Gy in 5 Fractions versus 27 Gy in 3 Fractions Radiotherapy for Treating Painful Bone Metastases: A Single Institution Experience.
    Sakr A; Hashem WB; Ebrahim N; Mashhour KN
    Asian Pac J Cancer Prev; 2020 Jun; 21(6):1807-1811. PubMed ID: 32592381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Net Pain Relief After Palliative Radiation Therapy for Painful Bone Metastases: A Useful Measure to Reflect Response Duration? A Further Analysis of the Dutch Bone Metastasis Study.
    Spencer K; Velikova G; Henry A; Westhoff P; Hall PT; van der Linden YM
    Int J Radiat Oncol Biol Phys; 2019 Nov; 105(3):559-566. PubMed ID: 31344434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic versus conventional radiotherapy for pain reduction and quality of life in spinal metastases: study protocol for a randomized controlled trial.
    Braam P; Lambin P; Bussink J
    Trials; 2016 Feb; 17():61. PubMed ID: 26829933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.